Christopher Reid

Reid Christopher.png

Christopher Reid is a cardiovascular epidemiologist and trialist with appointments as Research Professor in both the School of Public Health at Curtin University and the School of Public Health and Preventive Medicine, Monash University. He was appointed as a John Curtin Distinguished Professor in 2018 and is Director of the Monash and Curtin Centre’s of Cardiovascular Research and Education (CCRE) and the NHMRC Centre of Research Excellence in Cardiovascular Outcomes Improvement (2016-2020).  He holds a National Health and Medical Research Council Principal Research Fellowship (2018-2022) in addition to being the Chief Investigator on an NHMRC Program Grant (2016-2020) focusing on cardiovascular disease prevention.  He has been awarded over $113M as a Chief Investigator and has received continuous NHMRC funding since 2001.  His major research interests include clinical outcome registries, randomized controlled trials, and epidemiological cohort studies.  He has over 400 peer-reviewed publications, many of which are in leading journals including the New England Journal of Medicine, Lancet, JACC and the BMJ.  He has been Study Director for the 2nd Australian National Blood Pressure (ANBP2) Study and currently a Chief Investigator for the Aspirin in Reducing Events in the Elderly (ASPREE) Study, the Statins in Reducing Events in the elderly Trial and the Australian arms of the HOPE-3, REACH and CLARIFY Registries. He is a Principal Investigator for the Victorian Cardiac Procedures Registry Project, the Melbourne Interventional Group (MIG) registry, and the ANZSCTS National Cardiac Surgical Registry.  He is a Board Member of the Australian Clinical Trials Alliance, Chairs the ANZACT Clinical Trials Network and is Flagship Director for Clinical Trials of the Australia Cardiovascular Alliance.